GSK rises Wednesday, outperforms market
Shares of GSK PLC GSK inched up 0.94% to £14.01 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the FTSE 100 Index UKX rising 0.28% to 8,557.81. GSK ...
GSK falls Tuesday, underperforms market
GSK PLC closed 23.91% below its 52-week high of £18.24, which the company reached on May 16th.
GSK Pharma put volume heavy and directionally bearish
Bearish flow noted in GSK (GSK) Pharma with 1,694 puts trading, or 4x expected. Most active are 2/7 weekly 34 puts and Jan-27 28 puts, with total volume in those strikes near 1,600 contracts. The ...
GSK, Oxford to establish GSK-Oxford Cancer Immuno-Prevention Programme
GSK (GSK) and the University of Oxford announced that they have entered a new research collaboration focused on the potential of cancer ...
Hosted on MSN1d
GSK and University of Oxford partner for cancer vaccine research
GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...
GSK and Oxford researchers to create cancer vaccine to stop disease developing
GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.
STAT16d
Pharmalittle: We’re reading about J&J and GSK deals, a departing FDA official, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that familiar routine of deadlines, online meetings, and the like ...
The Motley Fool UK13d
AI thinks these could be the best FTSE 100 stocks to consider buying now
GSK, HSBC Holdings, and Vodafone Group Public. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make ...
VentureBeat15d
Hallucinations in AI: How GSK is addressing a critical problem in drug development
Learn More Pharmaceutical giant GSK is pushing the boundaries of what generative AI can achieve in healthcare areas like scientific literature review, genomic analysis and drug discovery.
Benzinga.com16d
STAT+: Pharmalittle: We're reading about J&J and GSK deals, a departing FDA official, and more
Seeking to build up its cancer business, GSK agreed to buy IDRx for $1 billion upfront, STAT notes. The deal, which includes another $150 million in milestone payments, gives GSK an experimental ...
The Motley Fool UK26d
2 cheap shares I’ve bought to build my wealth after 50
The Motley Fool UK has recommended GSK. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our ...
Building27d
High-profile team to transform former GSK headquarters
A high-profile team of architects, landscape designers, and consultants has been appointed to progress a masterplan for the redevelopment of the former GSK headquarters at 980 Great West Road, ...